SUMITOMO PHARMA CO., LTD. (FORMERLY SUNOVION PHARMACEUTICALS, INC.)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2011–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	1	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	5	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	6	1
2013	—	4	1
2012	—	5	1
2011	—	6	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
JEFFREY J. KIMBELL & ASSOCIATES, INC.	—	59

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	57
SENATE	57
Office of Management & Budget (OMB)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	59
Medicare/Medicaid	Medicare/Medicaid	27

SUMITOMO PHARMA CO., LTD. (FORMERLY SUNOVION PHARMACEUTICALS, INC.) — Lobbying Disclosure | Poliscope